Essex Life

Sciences, LLP

Fund Investment Objectives

The Essex Global Life Sciences Strategy seeks capital appreciation by investing in a diversified portfolio of listed medical and life science companies. These companies are focused in the areas of drug discovery and distribution, the production of devices and instrumentation, delivery of health care services, and the development and implementation of medical information technology. The portfolio is concentrated in a limited number of issues with market capitalizations greater than $100M. The strategy is benchmarked to the S&P 1500 Healthcare Index.